Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,224.00
Bid: 1,220.00
Ask: 1,224.00
Change: -6.00 (-0.49%)
Spread: 4.00 (0.328%)
Open: 1,200.00
High: 1,232.00
Low: 1,200.00
Prev. Close: 1,230.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Appointment

24 Mar 2015 07:01

RNS Number : 2535I
First Derivatives PLC
24 March 2015
 



24 March 2015

 

First Derivatives PLC

("FD" or the "Company")

 

Directorate Change and Appointment

 

FD (AIM:FDP.L, ESM:FDP.I), a leading provider of software and consulting services, announces the appointment of Pat Brazel as Global Head of Software Sales, following the acquisition of ActivateClients Limited detailed in a separate announcement earlier today. As a result of this appointment, Mr Brazel has stepped down as a Non-Executive Director of the Company with immediate effect.

 

The appointment of Mr Brazel strengthens the Company's executive leadership as it seeks to penetrate additional vertical sectors, using the capabilities of its Delta platform and kdb+ to capture and analyse big data, especially fast streaming information. He will work alongside Gerry Buggy, who will take up a new role as Chief Technology Officer.

 

Mr Brazel has more than 25 years' experience in the software industry, including nearly a decade as President of Sungard Capital Markets. He was also a founder of Sentry Financial Technology, now part of IBM and of GoldTier Technologies, which was acquired by Thomson Reuters in 2013.

 

Pat Brazel commented: "My time as a Non-Executive Director at FD has convinced me of the Company's potential to become the leading player in the emerging market for fast data and analytics. In my new role as Global Head of Software Sales, I look forward to helping FD realise this ambition."

 

Brian Conlon, Chief Executive Officer of FD, commented: "I am delighted to announce the appointment of Pat Brazel. His track record in driving sales at high-growth enterprise software companies will be extremely valuable to the Company. We continue to invest in our sales and marketing capability to meet a range of market opportunities, particularly as we execute on our strategy to enter new vertical markets."

 

 

 

Enquiries:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser and Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody Corporate Finance

(ESM Adviser and Broker)

Linda Hickey

+353 1 667 0420

Walbrook PR

Paul Cornelius

Sam Allen

Nick Rome

+44 (0)20 7933 8780

 

 

 

About First Derivatives

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. It holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It employs over 1,200 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry. For further information, please visit www.firstderivatives.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUSRARVWAOURR
Date   Source Headline
23rd Apr 20247:00 amRNSNotice of Results
22nd Apr 20244:11 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSHolding(s) in Company
15th Apr 20246:14 pmRNSIssue of Equity
8th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:14 pmRNSHolding(s) in Company
2nd Apr 20243:43 pmRNSHolding(s) in Company
2nd Apr 20243:26 pmRNSHolding(s) in Company
2nd Apr 20248:39 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20243:24 pmRNSHolding(s) in Company
19th Mar 20244:35 pmRNSIssue of Equity
18th Mar 20244:22 pmRNSHolding(s) in Company
15th Mar 20246:23 pmRNSHolding(s) in Company
15th Mar 20245:27 pmRNSCorrection - Holding(s) in Company
15th Mar 20245:20 pmRNSHolding(s) in Company
15th Mar 20244:43 pmRNSHolding(s) in Company
13th Mar 20245:15 pmRNSHolding(s) in Company
13th Mar 20244:34 pmRNSHolding(s) in Company
13th Mar 202410:45 amRNSHolding(s) in Company
11th Mar 202412:15 pmRNSHolding(s) in Company
11th Mar 202411:47 amRNSDirector/PDMR Shareholding
7th Mar 202410:57 amRNSHolding(s) in Company
6th Mar 20244:50 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSHolding(s) in Company
1st Mar 20247:00 amRNSConclusion of Structure Review
1st Mar 20247:00 amRNSFY24 Trading Update
15th Jan 20245:43 pmRNSHolding(s) in Company
19th Dec 20235:27 pmRNSCorrection: Holding(s) in Company
18th Dec 20237:00 amRNSHolding(s) in Company
15th Dec 20237:00 amRNSDirectorate Change
29th Nov 20237:00 amRNSKX hosts Investor Event: Winning in the AI Era
28th Nov 20237:00 amRNSLaunch of KDB.AI Server
22nd Nov 20231:54 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Nov 20238:57 amRNSDirector/PDMR Shareholding
13th Nov 20233:04 pmRNSHolding(s) in Company
6th Nov 20237:00 amRNSNotice of KX Investor Event
24th Oct 20237:00 amRNSResults for the six months ended 31 August 2023
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.